RESULTS	At week 12 in both studies , treatment with tazarotene foam led to greater decreases from baseline in mean absolute and percentage change in lesion counts ( noninflammatory , inflammatory , and total ) , greater proportion of participants with 2-grade improvement in ISGA score , and greater proportion of participants with ISGA score of 0 or 1 than vehicle treatment ( P < .001 for all ) .\